Showing results (2181-2190 of 2,235) with videos related to
Sort By:
Pageof 224
JCI Insight|August 12, 2020
Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosisDiana J Garay-Baquero, Cory H White, Naomi F Walker, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|March 12, 2014
New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligandsSerena Orbisaglia, Corrado Di Nicola, Fabio Marchetti, et al.Journal of Dairy Science|September 10, 2023
Estimation of genetic parameters for feed efficiency traits using random regression models in dairy cattleK Houlahan, F S Schenkel, F Miglior, et al.Diabetes|December 10, 2014
Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemiaNelly Mauras, Paul Mazaika, Bruce Buckingham, et al.Journal of Pain and Symptom Management|January 18, 2026
Core Elements of Goals of Care Initiatives Across Eight Health SystemsJessica E Ma, Gina Piscitello, Jane Schell, et al.Journal of Clinical and Translational Science|May 5, 2021
Planning for patient-reported outcome implementation: Development of decision tools and practical experience across four clinicsTherese A Nelson, Brigitte Anderson, Jiang Bian, et al.The Journal of Rheumatology|May 22, 2001
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupA M Huber, J E Hicks, P A Lachenbruch, et al.Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancyLaura C Matthews, Andrew A Berry, David J Morgan, et al.Arthritis and Rheumatism|May 18, 2004
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathiesAdam M Huber, Brian M Feldman, Robert M Rennebohm, et al.Molecular Cancer Therapeutics|October 26, 2019
Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung CancerKerry A Whalen, Brian H White, James M Quinn, et al.Pageof 224